Zealand Pharma shares plunge 25% after a quarter of patients drop out of obesity drug trial, raising concerns about tolerability.
Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Bending Spoons, owner of Vimeo, Evernote and AOL, files for IPO in the US, joining a wave of European tech firms seeking American listings.
Bending Spoons, which owns digital applications like Vimeo, Evernote and AOL, filed for an initial public offering, joining a string of European tech companies seeking US listings.
Tech sell-off halts AI rally, Middle East tensions push oil higher
Tumbling tech stocks halt AI rally, Middle East escalation lifts oil prices.
Tencent plans to raise $3 billion through a dual-currency bond offering in dollars and yuan, according to a company statement.
Tencent aims to raise $3 billion in a dollar and yuan bond offering.
Monte Paschi shares jump 10% to highest since 2022 on M&A proposals
Monte dei Paschi di Siena shares surged 10% to their highest level since 2022 following merger and acquisition proposals.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.